00000cam 2200000zi 4500 9.859811 CaOODSP 20251215100457 m o d f cr cn||||||||| 180730t20192019onc o f000 0 eng d 9780660274355 CaOODSP eng rda CaOODSP n-cn--- H13-9/18-2019E-PDF Guidance document : fees for the review of human and disinfectant drug submissions and applications. Fees for the review of human and disinfectant drug submissions and applications Ottawa, ON : Health Canada = Santé Canada, 2019. ©2019 1 online resource (21 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Ligne directrice : frais pour l'examen des présentations et des demandes de médicaments à usage humain et de désinfectants assimilés à une drogue. "Publication date: November 2019." "Pub.: 180194." "This document provides guidance on how fees for the review of human and disinfectant drug submissions and applications will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order and the Regulations Amending and Repealing Certain Regulations Made under the Financial Administration Act"--Objectives, page 6. Drug approval Canada. Fees, Administrative Canada. Canada. Health Canada, issuing body. Ligne directrice : (CaOODSP)9.859813 PDF 306 KB https://publications.gc.ca/collections/collection_2020/sc-hc/H13-9-18-2019-eng.pdf HTML N/A https://webarchiveweb.wayback.bac-lac.canada.ca/web/20250505013130/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications-2019/document.html